Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
Bayer
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
Institut Curie
Mayo Clinic
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Duke University
National Institutes of Health Clinical Center (CC)
Region Skane
Arbeitsgemeinschaft medikamentoese Tumortherapie
Tvardi Therapeutics, Incorporated
Labcorp Corporation of America Holdings, Inc
Cedars-Sinai Medical Center
Stanford University
Universitair Ziekenhuis Brussel
Eli Lilly and Company
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Institut Cancerologie de l'Ouest
National Institutes of Health Clinical Center (CC)
University of Southern California
Cedars-Sinai Medical Center
Exelixis
Celldex Therapeutics
NextCure, Inc.
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Klus Pharma Inc.
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
Fate Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Prelude Therapeutics
Herlev Hospital
Quadriga Biosciences, Inc.
Milton S. Hershey Medical Center
Institut de Cancérologie de Lorraine
Ludwig Institute for Cancer Research
Xencor, Inc.
Scripps Health
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey